Sponsor pipeline

Beijing Sanbo Brain Hospital clinical trial pipeline

Get alerts when Beijing Sanbo Brain Hospital's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 2
4
Not charted: 4 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT04070040 Camrelizumab for Patients with Recurrent Primary Central Nervous System Lymphoma (PCNSL) Primary Central Nervous System Lymphoma Recruiting 2024-10-15
NCT04267978 Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in… Glioblastoma, Recurrent Recruiting 2024-10-15
NCT04501718 Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent… Recurrent Medulloblastoma Recruiting 2024-10-15
NCT05278715 Modified CV Regimen in Optic Pathway Glioma Optic Glioma Recruiting 2024-10-15
Not applicable
NCT04501705 Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults Recurrent Atypical/malignant Meningioma Recruiting 2024-10-15
NCT07790224 Multi-Parameter Temporal Interference Stimulation in Patients With Epilepsy Undergoing… Epilepsy Not Yet Recruiting 2026-08-27
Not specified
NCT06894238 Electroencephalogram Predicts Post-operative Delirium Neurosurgery Recruiting 2025-03-25
NCT05836701 Retrospective Study of Germ Cell Tumors of the Central Nervous System Germ Cell Tumor of CNS Active, Not Recruiting 2024-10-15

Disease areas by active trials

Glioma (3) · Epilepsy (1) · Glioblastoma (1)

Get alerts when Beijing Sanbo Brain Hospital's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free